News from hospira, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 10, 2015, 03:00 ET

New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars, today announced the results of an independent clinical study, showing...

Jun 02, 2015, 10:00 ET

ANVISA Approves First Infliximab Biosimilar in Brazil

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical...

May 20, 2015, 09:00 ET

Hospira, Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States

 Hospira, Inc. (NYSE: HSP) joined forces with the Alliance for Health Reform and Amgen to bring the U.S. Food and Drug Administration (FDA) and...

May 13, 2015, 13:40 ET

Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Apr 28, 2015, 07:30 ET

Hospira Reports First-Quarter 2015 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Apr 25, 2015, 06:25 ET

Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation

- Hospira fordert die fortdauernde Unterstützung des Extrapolations-Prinzips, um verstärkten Zugang von Patienten zu lebensrettenden...

Apr 25, 2015, 04:40 ET

La direction de Hospira fait une présentation à un forum européen prééminent sur les biosimilaires et annonce un nouveau livre blanc sur l'extrapolation

- Hospira appelle à un soutien continu du principe de l'extrapolation afin de promouvoir l'accès des patients à des médicaments...

Apr 24, 2015, 07:41 ET

Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation

Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, spoke about the importance of extrapolation in bringing...

Apr 13, 2015, 08:30 ET

Esperanza para un acceso mejor de los pacientes a los medicamentos biosimilares

Hospira, Inc. (NYSE: HSP), principal proveedor mundial de fármacos inyectables y tecnologías de infusión, además de líder...

Apr 13, 2015, 03:30 ET

Les patients pourraient bénéficier d'un meilleur accès aux médicaments biosimilaires

Hospira, Inc. (NYSE : HSP), le plus grand fournisseur mondial de médicaments injectables et de technologies d'infusion, et leader mondial...

Apr 13, 2015, 03:30 ET

Hoffnung für besseren Zugriff der Patienten auf biosimilare Medikamente

Hospira, Inc. (NYSE: HSP),der weltweit führende Anbieter von injizierbaren Arzneistoffen und Infusionstechnologien und ein globaler...

Apr 13, 2015, 03:30 ET

Hope for Greater Access for Patients to Biosimilar Medicines

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, said at...

Apr 07, 2015, 16:30 ET

Hospira to Announce First-Quarter 2015 Results on April 28, 2015

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Mar 30, 2015, 11:30 ET

Hospira's INFLECTRA™ (Infliximab) Now Available in Canada

-- Subsequent entry biologic (SEB) medicine provides a lower-cost, high-quality, safe and effective therapy for rheumatoid arthritis (RA),...

Mar 27, 2015, 09:00 ET

Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies,...

Mar 06, 2015, 11:39 ET

Hospira Statement on FDA Approval of the First Biosimilar in the United States

 Hospira, Inc. (NYSE: HSP), applauds Sandoz and the U.S. Food and Drug Administration (FDA) on today's FDA approval of the first biosimilar in...

Feb 19, 2015, 06:07 ET

Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

 Data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first approved biosimilar monoclonal antibody...

Feb 16, 2015, 04:55 ET

Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets

 Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch of the first biosimilar...